Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study

Peter, 2014, Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings, Eur Respir J, 43, 185, 10.1183/09031936.00198012 Steingart, 2014, Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults, Cochrane Database Syst Rev, 1 García-Basteiro, 2018, Point of care diagnostics for tuberculosis, Pulmonology, 24, 73, 10.1016/j.rppnen.2017.12.002 2017 Chakravorty, 2017, The new Xpert MTB/RIF Ultra: improving detection of Mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing, MBio, 8, e00812, 10.1128/mBio.00812-17 Dorman, 2018, Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study, Lancet Infect Dis, 18, 76, 10.1016/S1473-3099(17)30691-6 Horne, 2019, Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults, Cochrane Database Syst Rev, 6 Berhanu, 2018, Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott Real Time MTB for the diagnosis of pulmonary tuberculosis in a high HIV burden setting, J Clin Microbiol, 56, e00560, 10.1128/JCM.00560-18 2017 Theron, 2016, Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results?, Clin Infect Dis, 62, 995, 10.1093/cid/civ1223 Marx, 2014, The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study, Clin Infect Dis, 58, 1676, 10.1093/cid/ciu186 Nunn, 2010, Timing of relapse in short-course chemotherapy trials for tuberculosis, Int J Tuberc Lung Dis, 14, 241 Marx, 2018, Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study, Lancet Glob Health, 6, e426, 10.1016/S2214-109X(18)30022-6 Kendall, 2017, Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: a modeling study, PLoS Med, 14, 10.1371/journal.pmed.1002472 García-Basteiro, 2017, The good, the bad and the ugly of the next-generation Xpert Mtb/Rif Ultra test for tuberculosis diagnosis, Arch Bronconeumol, 53, 665, 10.1016/j.arbres.2017.05.023 2019 Wood, 2011, Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status, PLoS One, 6, 10.1371/journal.pone.0025098 2019 2013 Rudolf, 2013, TBscore II: refining and validating a simple clinical score for treatment monitoring of patients with pulmonary tuberculosis, Scand J Infect Dis, 45, 825, 10.3109/00365548.2013.826876 Harris, 2009, Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, 42, 377, 10.1016/j.jbi.2008.08.010 Rieder, 1998 Shenai, 2016, Bacterial loads measured by the Xpert MTB/RIF assay as markers of culture conversion and bacteriological cure in pulmonary TB, PLoS One, 11, 10.1371/journal.pone.0160062 Cohen, 2016, STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration, BMJ Open, 6, 10.1136/bmjopen-2016-012799 Theron, 2018, False-positive Xpert MTB/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes, J Clin Microbiol, 56, e01696, 10.1128/JCM.01696-17 de Vos, 2018, Diagnostic accuracy and utility of FluoroType MTBDR, a new molecular assay for multidrug-resistant tuberculosis, J Clin Microbiol, 56, e00531, 10.1128/JCM.00531-18 Simel, 1987, Intermediate, indeterminate, and uninterpretable diagnostic test results, Med Decis Making, 7, 107, 10.1177/0272989X8700700208 Albert, 2016, Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?, Eur Respir J, 48, 516, 10.1183/13993003.00543-2016 Gumma, 2019, Impact of external quality assurance on the quality of Xpert MTB/RIF testing in Viet Nam, J Clin Microbiol, 57, e01669, 10.1128/JCM.01669-18 Theron, 2014, Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?, Lancet Infect Dis, 14, 527, 10.1016/S1473-3099(13)70360-8 Datta, 2017, Improving tuberculosis diagnosis: Better tests or better healthcare?, PLoS Med, 14, 10.1371/journal.pmed.1002406